A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer von Michels, J., Ellard, S.L., Le, L., Kollmannsberger, C., Murray, N., Tomlinson Guns, E.S., Carr, R., Chi, K.N.

Volltext